1177.HK - Sino Biopharmaceutical Limited

HKSE - HKSE Delayed Price. Currency in HKD
Currency in HKD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2023)Next year (2024)
No. of analysts011616
Avg. Estimate065.110.210.23
Low estimate065.110.170.19
High estimate065.110.260.29
Year ago EPSN/AN/A0.180.21
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2023)Next year (2024)
No. of analysts1901919
Avg. Estimate35.97BN/A35.97B40.24B
Low estimate34.95BN/A34.95B38.43B
High estimate37.4BN/A37.4B42.32B
Year ago sales31.76BN/A31.76B35.97B
Sales growth (year/est)13.20%N/A13.20%11.90%
Earnings historyInvalid DateInvalid DateInvalid Date30/06/2021
Est. EPSN/AN/AN/A0.13
Actual EPSN/AN/AN/A0.4
DifferenceN/AN/AN/A0.27
Surprise %N/AN/AN/A207.70%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2023)Next year (2024)
Current estimate065.110.210.23
7 days ago0.0665.290.210.24
30 days ago0.0667.650.220.25
60 days ago0.0600.230.26
90 days ago0.0600.240.27
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimates1177.HKIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year16.70%N/AN/AN/A
Next year9.50%N/AN/AN/A
Next 5 years (per annum)21.62%N/AN/AN/A
Past 5 years (per annum)41.42%N/AN/AN/A